Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors

Running, not enrolling · Early Phase 1

Conditions studied: Acute Myeloid Leukemia, Myeloid Leukemia, Recurrent Acute Myeloid Leukemia

In brief

This clinical trial assesses how the immune system responds to leukemia tumors after low dose radiation delivered as part of standard of care. The information learned in this study may help them know if adding immunotherapy (a type of treatment that uses the immune system to fight cancer) can be helpful in future leukemia patients receiving radiation.

Key facts

Study ID
NCT05035706
Run by
M.D. Anderson Cancer Center
People needed
10
Starts
2021-06-30
Expected to finish
2026-04-30
Last updated by the study team
2026-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.